February 8, 2024
Philip Morris International Reports 2023 Fourth-Quarter and Full-Year Results; Delivers 2023 Full-Year Reported Diluted EPS of $5.02 and Adjusted Diluted EPS of $6.01, Representing Currency-Neutral Growth of 11.0%; Provides 2024 EPS Forecast
Download2023 FOURTH-QUARTER AND FULL-YEAR HIGHLIGHTS
|
|
Fourth-Quarter |
|
Full-Year |
||||||||||
|
|
|
|
Change vs. Q4 2022 |
|
|
Change vs. FY 2022 |
|||||||
|
|
Amount |
|
Reported |
|
Adjusted |
|
Amount |
Reported |
|
Adjusted |
|||
Total Cig. & HTU Shipment Volume (units bn) |
|
185.1 |
|
(0.5)% |
|
|
|
|
738.2 |
1.0% |
|
|
|
|
HTU Shipment Volume (units bn) |
|
34.0 |
|
6.1% |
|
|
|
|
125.3 |
14.7% |
|
|
|
|
Oral Product Shipment Volume (mn cans) (1) |
|
219.6 |
|
+100% |
|
23.4% |
(2) |
|
799.3 |
+100% |
|
16.8% |
(2) |
|
Net Revenues ($ bn) |
|
|
|
11.0% |
|
8.3% |
(3) |
|
|
10.7% |
|
7.8% |
(3) |
|
Smoke-Free Product Net Revenues ($ bn) |
|
|
|
21.1% |
|
13.6% |
(3) |
|
|
26.0% |
|
12.8% |
(3) |
|
- % of Total Net Revenues |
|
39.3% |
|
3.3pp |
|
|
|
|
36.5% |
4.4pp |
|
|
|
|
Operating Income ($ bn) |
|
|
|
(1.2)% |
|
8.0% |
(3) |
|
|
(5.6)% |
|
3.7% |
(3) |
|
Diluted Earnings per Share |
|
|
|
(8.4)% |
|
|
|
|
|
(13.6)% |
|
|
|
|
Adjusted Diluted Earnings per Share |
|
|
|
|
|
12.2% |
(4) |
|
|
|
|
11.0% |
(4) |
|
(1) Excludes snuff, snuff leaf and |
||||||||||||||
(2) On a pro forma basis (including |
||||||||||||||
(3) On an organic basis |
||||||||||||||
(4) Excluding currency |
Fourth-Quarter
- Smoke-free products accounted for 39.3% of total net revenues
- Adjusted in-market sales volume for HTUs, which excludes the net unfavorable impact of estimated distributor and wholesaler inventory movements, up by an estimated 13.9%
- Total IQOS users at quarter-end up by 1.2 million versus
September 2023 - Market share for HTUs in IQOS markets up by 1.3 points to 9.7%
- ZYN nicotine pouch shipment volume in the
U.S. of 116.3 million cans, representing growth of 78.2% versus fourth-quarter 2022Swedish Match shipments of 65.3 million cans - Combustible tobacco net revenue growth of 5.3% on both a reported and organic basis, driven by pricing of 9.9%
Full-Year
- Third consecutive year of volume growth driven by HTUs
- Adjusted in-market sales volume for HTUs, which excludes the net unfavorable impact of estimated distributor and wholesaler inventory movements, up by an estimated 14.8%
- Total IQOS users at year-end estimated at approximately 28.6 million (up by 3.7 million versus
December 2022 ), of which approximately 20.8 million had switched to IQOS and stopped smoking - Market share for HTUs in IQOS markets up by 1.2 points to 9.1%
- ZYN nicotine pouch shipment volume in the
U.S. of 384.8 million cans, representing growth of 62.0% versus 2022Swedish Match shipments of 237.5 million cans - Increased regular quarterly dividend in September by 2.4% to
$1.30 per share, or an annualized rate of$5.20 per share - Combustible tobacco net revenue growth of 3.5%; growth of 5.5% on an organic basis, driven by pricing of 8.9%
- Organic growth in adjusted operating income driven by the performance of smoke-free products
"Our business delivered a strong finish to 2023 and we achieved a number of remarkable milestones on our path to becoming a smoke-free company," said
"We are pleased that smoke-free products reached nearly 40% of our total net revenues and over 40% of our gross profit in the fourth quarter. This was led by the continued growth of IQOS, which has now surpassed Marlboro in terms of net revenues, confirming its position as the leading premium nicotine brand less than 10 years from launch. The fourth quarter also marked the first anniversary of our combination with
"We are entering 2024 with strong momentum, and we expect it will be another year of excellent performance underpinned by an acceleration in organic smoke-free net revenue and profit growth."
2023 FULL-YEAR SUMMARY
Adjusted net revenues increased by 7.8% on an organic basis, driven by total cigarette and HTU shipment volume growth of 1.0% (reflecting growth of 14.7% for HTUs and a decline of 1.4% for cigarettes), favorable category mix of smoke-free products and positive pricing.
Adjusted operating income increased by 3.7% on an organic basis with a substantial acceleration in the second half of the year, as supply chain disruptions and ILUMA-related factors continued to dissipate, coupled with an accelerating contribution from smoke-free products.
Adjusted diluted EPS of
|
|
Full-Year |
|||||||||||||
|
|
2023 |
|
2022 |
|
Currency |
|
Var. excl. |
|||||||
Reported Diluted EPS |
|
$ |
5.02 |
|
$ |
5.81 |
|
$ |
(0.63 |
) |
(2.8 |
)% |
|||
Asset impairment and exit costs |
|
|
0.06 |
|
|
— |
|
|
|
||||||
Termination of distribution arrangement in the |
|
|
0.04 |
|
|
— |
|
|
|
||||||
Income tax impact associated with |
|
|
(0.11 |
) |
|
(0.13 |
) |
|
|
||||||
|
|
|
0.01 |
|
|
0.06 |
|
|
|
||||||
Impairment of goodwill and other intangibles |
|
|
0.44 |
|
|
0.06 |
|
|
|
||||||
Amortization of intangibles |
|
|
0.25 |
|
|
0.09 |
|
|
|
||||||
Charges related to the war in |
|
|
0.03 |
|
|
0.08 |
|
|
|
||||||
Costs associated with |
|
|
— |
|
|
0.06 |
|
|
|
||||||
|
|
|
0.11 |
|
|
— |
|
|
|
||||||
Termination of agreement with |
|
|
0.07 |
|
|
— |
|
|
|
||||||
Fair value adjustment for equity security investments |
|
|
(0.02 |
) |
|
(0.02 |
) |
|
|
||||||
Tax items (1) |
|
|
0.11 |
|
|
(0.03 |
) |
|
|
||||||
Adjusted Diluted EPS |
|
$ |
6.01 |
|
$ |
5.98 |
|
$ |
(0.63 |
) |
11.0 |
% |
|||
(1) 2023 Tax items relate to the unilateral suspension of certain Russian double tax treaties by the Russian government |
2024 FULL-YEAR FORECAST
|
Full-Year |
|||||||||||
|
2024 Forecast |
|
2023 |
|
Growth |
|||||||
|
|
|
|
|
|
|
|
|
||||
Reported Diluted EPS |
|
- |
|
|
|
|
|
|
|
|||
Adjustments: |
|
|
|
|
|
|
|
|
|
|||
Asset impairment and exit costs |
— |
|
0.06 |
|
|
|
|
|||||
Termination of distribution arrangement in the |
— |
|
0.04 |
|
|
|
|
|||||
Income tax impact associated with |
— |
|
(0.11) |
|
|
|
|
|||||
Amortization of intangibles |
0.42 |
|
0.25 |
|
|
|
|
|||||
Impairment of goodwill and other intangibles |
— |
|
0.44 |
|
|
|
|
|||||
Charges related to the war in |
— |
|
0.03 |
|
|
|
|
|||||
|
— |
|
0.01 |
|
|
|
|
|||||
Termination of agreement with |
— |
|
0.07 |
|
|
|
|
|||||
|
— |
|
0.11 |
|
|
|
|
|||||
Fair value adj. for equity security investments |
— |
|
(0.02) |
|
|
|
|
|||||
Tax items (1) |
— |
|
0.11 |
|
|
|
|
|||||
Total Adjustments |
0.42 |
|
0.99 |
|
|
|
|
|||||
Adjusted Diluted EPS |
|
- |
|
|
|
|
|
|
|
|||
Less: Currency |
(0.11) |
|
|
|
|
|
|
|||||
Adjusted Diluted EPS, excluding currency |
|
- |
|
|
|
|
7.0% |
- |
9.0% |
|||
(1) 2023 Tax items relate to the unilateral suspension of certain Russian double tax treaties by the Russian government |
Reported diluted EPS is forecast to be in a range of
2024 Full-Year Forecast Assumptions
This forecast assumes:
- An estimated total international industry volume decline for cigarettes and HTUs, excluding
China and theU.S. , of -2% to flat; - Total cigarette, HTU and oral smoke-free product shipment volume growth for PMI of flat to +1% driven by smoke-free products;
- 14% to 16% adjusted in-market sales volume growth for HTUs, including an approximate 2 billion units adverse impact from consumer adjustment to the EU characterizing flavor ban, and essentially no growth in
Russia , resulting in HTU shipment volumes of more than 140 billion units; - Nicotine pouch shipment volume in the
U.S. of approximately 520 million cans; - Net revenue growth of 6.5% to 8% on an organic basis;
- Organic operating income growth of 8% to 9.5%;
- An acceleration in organic smoke-free net revenue and gross profit growth compared to 2023;
- Broadly unchanged net revenue and adjusted operating loss in Wellness and Healthcare segment;
- No earnings impact from any potential favorable court ruling related to the legality of a supplemental tax surcharge on HTUs in
Germany , which went into effect in 2022 (see PMI's first-quarter 2023 press release fromApril 20, 2023 , for additional detail). The company currently expects to have greater visibility on the outcome in the first quarter of 2024; - Full-year amortization of acquired intangibles of
$0.42 per share, which includes an estimate of amortization of IQOS commercialization rights in theU.S. following the closing of the agreement to end our commercial relationship with Altria Group, Inc. covering IQOS in theU.S. effectiveMay 1, 2024 . We currently estimate that the incremental increase in amortization expense in 2024, as a result of this transaction, will be approximately$370 million on a pre-tax basis for the remaining 8 months of the year. For full year 2025 through 2028, we currently estimate an annual impact of approximately$555 million on a pre-tax basis; - Net financing costs of approximately
$1.3 to$1.4 billion ; - An effective tax rate, excluding discrete tax events, of approximately 21% to 22%;
- Operating cash flow of
$10 to$11 billion at prevailing exchange rates, subject to year-end working capital requirements; - Capital expenditures of approximately
$1.2 billion , partly reflecting investments in ZYN capacity in theU.S. ; - Net debt to adjusted EBITDA ratio improvement of 0.3x to 0.5x at prevailing exchange rates as we continue to target a ratio of around 2x by the end of 2026;
- No share repurchases in 2024; and
- A strong start to 2024 with first quarter adjusted diluted EPS of
$1.37 to$1.42 , including an estimated adverse currency impact of10 cents at prevailing exchange rates.
Factors described in the Forward-Looking and Cautionary Statements section of this release represent continuing risks to these projections.
New Segment Structure
Following the combination and the progress in 2023 toward integration of the
Global Patent Settlement
On
Conference Call
A conference call hosted by
TOTAL MARKET, CONSOLIDATED SHIPMENT VOLUME & MARKET SHARE
Total Market Volume
Full-Year
Estimated international industry volume (excluding
Consolidated Shipment Volume
PMI Cigarettes and HTUs |
Fourth-Quarter |
Full-Year |
||||||||||
(million units) |
2023 |
2022 |
Change |
2023 |
2022 |
Change |
||||||
Cigarettes |
151,094 |
154,026 |
(1.9)% |
612,949 |
621,908 |
(1.4)% |
||||||
Heated Tobacco Units |
33,972 |
32,021 |
6.1% |
125,263 |
109,169 |
14.7% |
||||||
Total Cigarettes and HTUs |
185,066 |
186,047 |
(0.5)% |
738,212 |
731,077 |
1.0% |
PMI Oral Products (1) |
Fourth-Quarter |
Full-Year |
||||||||||
(million cans) |
2023 |
2022 |
Change |
2023 |
2022 |
Change |
||||||
Nicotine Pouches |
125.7 |
39.8 |
+100% |
421.1 |
42.5 |
+100% |
||||||
Snus |
61.8 |
42.8 |
44.4% |
240.4 |
54.8 |
+100% |
||||||
Moist Snuff |
31.2 |
16.0 |
95.5% |
133.7 |
16.0 |
+100% |
||||||
Other |
0.8 |
— |
—% |
4.2 |
— |
—% |
||||||
Total Oral Products |
219.6 |
98.6 |
+100% |
799.3 |
113.2 |
+100% |
||||||
(1) Excluding snuff, snuff leaf and |
||||||||||||
Note: Sum may not foot due to roundings. |
Fourth-Quarter
PMI's total cigarette and HTU shipment volume decreased by 0.5%, reflecting an 6.1% increase in HTU shipments across all regions except EA, AU &
PMI’s total oral product shipment volume increased by over 100%, driven by the
Adjusted in-market sales for HTUs increased by 13.9%, including growth in
Full-Year
PMI's total cigarette and HTU shipment volume increased by 1.0%, reflecting an 14.7% increase in HTU shipments across all regions, partly offset by a 1.4% decline in cigarette shipments due to declines in the
PMI’s total oral product shipment volume increased by over 100%, driven by the
Adjusted in-market sales for HTUs increased by 14.8% (in line with full-year HTUs shipment volume growth of 14.7%), including growth in
International Share of Market - Cigarettes and HTUs
|
Fourth-Quarter |
Full Year |
||||||||||
2023 |
2022 |
Change |
2023 |
2022 |
Change |
|||||||
|
|
|
|
|
|
|
||||||
Total International Market Share (1) |
28.6% |
28.1% |
0.5 |
28.3% |
27.7% |
0.6 |
||||||
Cigarettes |
23.7% |
23.7% |
— |
23.7% |
23.6% |
0.1 |
||||||
HTU |
4.9% |
4.3% |
0.6 |
4.7% |
4.1% |
0.6 |
||||||
Cigarette over Cigarette Market Share (2) |
25.3% |
25.2% |
0.1 |
25.2% |
25.0% |
0.2 |
||||||
(1) Defined as PMI's cigarette and heated tobacco unit in-market sales volume as a percentage of total industry cigarette and heated tobacco unit sales volume, excluding |
||||||||||||
(2) Defined as PMI's cigarette in-market sales volume as a percentage of total industry cigarette sales volume, excluding |
||||||||||||
Note: Sum of share of market by product categories might not foot to total due to roundings. |
CONSOLIDATED FINANCIAL SUMMARY
Fourth-Quarter
Financial Summary - Quarters Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
||||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net Revenues |
|
$ |
9,047 |
|
$ |
8,152 |
|
|
11.0 |
% |
8.3 |
% |
|
895 |
|
(78 |
) |
299 |
|
631 |
50 |
|
(7 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Cost of Sales (1) |
|
|
(3,462 |
) |
|
(3,211 |
) |
|
(7.8 |
)% |
(3.8 |
)% |
|
(251 |
) |
(39 |
) |
(90 |
) |
— |
(103 |
) |
(19 |
) |
|||||||
Marketing, Administration and Research Costs (2) |
|
|
(2,696 |
) |
|
(2,017 |
) |
|
(33.7 |
)% |
(19.0 |
)% |
|
(679 |
) |
(184 |
) |
(112 |
) |
— |
— |
|
(383 |
) |
|||||||
Operating Income |
|
$ |
2,889 |
|
$ |
2,924 |
|
|
(1.2 |
)% |
5.8 |
% |
|
(35 |
) |
(301 |
) |
97 |
|
631 |
(53 |
) |
(409 |
) |
|||||||
Amortization of Intangibles |
|
|
(129 |
) |
|
(58 |
) |
|
-(100 |
)% |
(51.7 |
)% |
|
(71 |
) |
— |
|
(41 |
) |
— |
— |
|
(30 |
) |
|||||||
Charges related to the war in |
|
|
(34 |
) |
|
(23 |
) |
|
(47.8 |
)% |
(47.8 |
)% |
|
(11 |
) |
— |
|
— |
|
— |
— |
|
(11 |
) |
|||||||
Costs associated with |
|
|
— |
|
|
154 |
|
|
-(100 |
)% |
-(100 |
)% |
|
(154 |
) |
— |
|
— |
|
— |
— |
|
(154 |
) |
|||||||
|
|
|
— |
|
|
(125 |
) |
|
+100 |
% |
+100 |
% |
|
125 |
|
— |
|
— |
|
— |
— |
|
125 |
|
|||||||
Adjusted Operating Income |
|
$ |
3,052 |
|
$ |
2,976 |
|
|
2.6 |
% |
8.0 |
% |
|
76 |
|
(301 |
) |
138 |
|
631 |
(53 |
) |
(339 |
) |
|||||||
Adjusted Operating Income Margin |
|
|
33.7 |
% |
|
36.5 |
% |
|
(2.8 |
)pp |
(0.1 |
)pp |
|
|
|
|
|
|
|
||||||||||||
(1) Includes |
|||||||||||||||||||||||||||||||
(2) Includes |
Net revenues increased by 8.3% on an organic basis, mainly reflecting: a favorable pricing variance, primarily driven by higher combustible tobacco pricing; and favorable volume/mix, mainly driven by higher HTU volume, partially offset by lower cigarette volume.
Adjusted operating income increased by 8.0% on an organic basis, mainly reflecting: the favorable pricing variance; partially offset by higher marketing, administration and research costs (primarily due to inflationary impacts, notably related to wages) as well as higher manufacturing costs. Slightly unfavorable volume/mix, mainly driven by lower cigarette volume, was partly offset by higher HTU volume.
Full-Year
Financial Summary - Years Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ |
|
Cost/ |
||||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net Revenues |
|
$ |
35,174 |
|
$ |
31,762 |
|
|
10.7 |
% |
7.6 |
% |
|
3,412 |
|
(1,112 |
) |
2,113 |
|
1,940 |
664 |
|
(193 |
) |
|||||||
Termination of distribution arrangement in the |
|
|
(80 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(80 |
) |
— |
|
— |
|
— |
— |
|
(80 |
) |
|||||||
Adjusted Net Revenues |
|
$ |
35,254 |
|
$ |
31,762 |
|
|
11.0 |
% |
7.8 |
% |
|
3,492 |
|
(1,112 |
) |
2,113 |
|
1,940 |
664 |
|
(113 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Net Revenues |
|
$ |
35,174 |
|
$ |
31,762 |
|
|
10.7 |
% |
7.6 |
% |
|
3,412 |
|
(1,112 |
) |
2,113 |
|
1,940 |
664 |
|
(193 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Cost of Sales (1) |
|
|
(12,893 |
) |
|
(11,402 |
) |
|
(13.1 |
)% |
(8.4 |
)% |
|
(1,491 |
) |
167 |
|
(695 |
) |
— |
(755 |
) |
(208 |
) |
|||||||
Marketing, Administration and Research Costs (2) |
|
|
(10,060 |
) |
|
(8,114 |
) |
|
(24.0 |
)% |
(13.5 |
)% |
|
(1,946 |
) |
(128 |
) |
(724 |
) |
— |
— |
|
(1,094 |
) |
|||||||
Impairment of |
|
|
(665 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(665 |
) |
— |
|
— |
|
— |
— |
|
(665 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Operating Income |
|
$ |
11,556 |
|
$ |
12,246 |
|
|
(5.6 |
)% |
(2.5 |
)% |
|
(690 |
) |
(1,073 |
) |
694 |
|
1,940 |
(91 |
) |
(2,160 |
) |
|||||||
Asset Impairment & Exit Costs |
|
|
(109 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(109 |
) |
— |
|
— |
|
— |
— |
|
(109 |
) |
|||||||
Termination of distribution arrangement in the |
|
|
(80 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(80 |
) |
— |
|
— |
|
— |
— |
|
(80 |
) |
|||||||
Impairment of |
|
|
(680 |
) |
|
(112 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(568 |
) |
— |
|
— |
|
— |
— |
|
(568 |
) |
|||||||
Amortization of Intangibles |
|
|
(497 |
) |
|
(159 |
) |
|
-(100 |
)% |
(14.5 |
)% |
|
(338 |
) |
— |
|
(315 |
) |
— |
— |
|
(23 |
) |
|||||||
Charges related to the war in |
|
|
(53 |
) |
|
(151 |
) |
|
64.9 |
% |
64.9 |
% |
|
98 |
|
— |
|
— |
|
— |
— |
|
98 |
|
|||||||
Costs associated with |
|
|
— |
|
|
(115 |
) |
|
+100 |
% |
+100 |
% |
|
115 |
|
— |
|
— |
|
— |
— |
|
115 |
|
|||||||
|
|
|
(18 |
) |
|
(125 |
) |
|
85.6 |
% |
+100 |
% |
|
107 |
|
— |
|
(18 |
) |
— |
— |
|
125 |
|
|||||||
South Korea Indirect Tax Charge |
|
|
(204 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(204 |
) |
— |
|
— |
|
— |
— |
|
(204 |
) |
|||||||
Termination of agreement with |
|
|
(140 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(140 |
) |
— |
|
— |
|
— |
— |
|
(140 |
) |
|||||||
Adjusted Operating Income |
|
$ |
13,337 |
|
$ |
12,908 |
|
|
3.3 |
% |
3.7 |
% |
|
429 |
|
(1,073 |
) |
1,027 |
|
1,940 |
(91 |
) |
(1,374 |
) |
|||||||
Adjusted Operating Income Margin |
|
|
37.8 |
% |
|
40.6 |
% |
|
(2.8 |
)pp |
(1.5 |
)pp |
|
|
|
|
|
|
|
||||||||||||
(1) Includes |
|||||||||||||||||||||||||||||||
(2) Includes |
|||||||||||||||||||||||||||||||
(3) Included in Net Revenues above. |
|||||||||||||||||||||||||||||||
(4) Includes |
Adjusted net revenues increased by 7.8% on an organic basis, mainly reflecting: a favorable pricing variance, primarily driven by higher combustible tobacco pricing, and favorable volume/mix, mainly driven by higher HTU volume, partially offset by lower cigarette volume and lower fees for certain distribution rights billed to customers in certain markets.
Cost of sales, excluding currency and acquisitions, increased by 8.4%, driven by higher manufacturing costs (primarily due to inflationary impacts, notably related to direct materials, tobacco leaf and energy, partly offset by productivity) and unfavorable volume/mix, mainly reflecting unfavorable category mix (notably due to lower cigarette volume and higher HTU volume), as well as the technical impact of third-party manufacturing in
Adjusted operating income increased by 3.7% on an organic basis, mainly reflecting: the favorable pricing variance; partly offset by higher marketing, administration and research costs (primarily due to inflationary impacts, notably related to wages, and lower commercial investments in the prior year period); higher manufacturing costs (as explained for cost of sales); and the impact of lower fees for certain distribution rights, as noted for net revenues.
Total Market, PMI Shipment & Market Share Commentaries
Europe Key Data |
Fourth-Quarter |
Full-Year |
||||||||||||||||
|
|
|
Change |
|
|
Change |
||||||||||||
|
2023 |
|
2022 |
|
% / pp |
2023 |
|
2022 |
|
% / pp |
||||||||
PMI Shipment Volume (million units) |
|
|
|
|
|
|
||||||||||||
Cigarettes |
39,330 |
|
39,339 |
|
— |
% |
165,593 |
|
170,658 |
|
(3.0 |
)% |
||||||
Heated Tobacco Units |
14,310 |
|
12,921 |
|
10.7 |
% |
49,269 |
|
45,417 |
|
8.5 |
% |
||||||
Total |
53,640 |
|
52,260 |
|
2.6 |
% |
214,862 |
|
216,075 |
|
(0.6 |
)% |
||||||
|
|
|
|
|
|
|
||||||||||||
PMI Market Share |
|
|
|
|
|
|
||||||||||||
Cigarettes |
30.3 |
% |
30.6 |
% |
(0.3 |
) |
30.3 |
% |
31.1 |
% |
(0.8 |
) |
||||||
Heated Tobacco Units |
10.0 |
% |
8.9 |
% |
1.1 |
|
9.1 |
% |
7.8 |
% |
1.3 |
|
||||||
Total |
40.3 |
% |
39.5 |
% |
0.8 |
|
39.4 |
% |
39.0 |
% |
0.4 |
|
||||||
Note: Sum may not foot due to roundings. |
Fourth-Quarter
The estimated total market for cigarettes and HTUs in the Region decreased by 0.9% to 130.8 billion units, reflecting a 2.6% decline for cigarettes, partly offset by a 13.2% increase for HTUs. The decrease in the estimated total market was predominantly due to the
PMI's total cigarette and HTU shipment volume in the Region increased by 2.6% to 53.6 billion units, mainly due to
PMI's estimated HTU adjusted in-market sales volume in the Region increased by 13.1% in the quarter, reflecting the strong continued growth momentum for IQOS (including in
PMI's HTU share of the total cigarette and HTU market in the Region increased by 1.1 points, or by 1.2 points on an adjusted basis.
Full-Year
The estimated total market for cigarettes and HTUs in the Region decreased by 1.3% to 542.3 billion units, reflecting a 3.0% decline for cigarettes, partly offset by a 15.6% increase for HTUs. The decrease in the estimated total market was predominantly due to the
PMI's total cigarette and HTU shipment volume in the Region decreased by 0.6% to 214.9 billion units, mainly due to
PMI's estimated HTU adjusted in-market sales volume in the Region increased by 17.6%, including growth in
PMI's HTU share of the total cigarette and HTU market in the Region increased by 1.3 points, or by 1.5 points on an adjusted basis.
Financial Summary
Fourth-Quarter
Financial Summary - Quarters Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ Mix |
|
Cost/ Other |
|||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Net Revenues |
|
$ |
3,614 |
|
$ |
3,064 |
|
|
18.0 |
% |
9.6 |
% |
|
550 |
|
255 |
— |
187 |
108 |
— |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Operating Income |
|
$ |
1,566 |
|
$ |
1,355 |
|
|
15.6 |
% |
6.6 |
% |
|
211 |
|
122 |
— |
187 |
146 |
(244 |
) |
|||||||
Adjustments (1) |
|
|
(44 |
) |
|
38 |
|
|
-(100 |
)% |
-(100 |
)% |
|
(82 |
) |
— |
— |
— |
— |
(82 |
) |
|||||||
Adjusted Operating Income |
|
$ |
1,610 |
|
$ |
1,317 |
|
|
22.2 |
% |
13.0 |
% |
|
293 |
|
122 |
— |
187 |
146 |
(162 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Adjusted Operating Income Margin |
|
|
44.5 |
% |
|
43.0 |
% |
|
1.5 |
pp |
1.3 |
pp |
|
|
|
|
|
|
|
|||||||||
(1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated |
Net revenues increased by 9.6% on an organic basis, reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; and favorable volume/mix, primarily driven by higher HTU volume and favorable mix, partly offset by lower cigarette volume, as well as unfavorable cigarette mix.
Adjusted operating income increased by 13.0% on an organic basis, primarily reflecting: the favorable pricing variance; favorable volume/mix, mainly reflecting higher HTU volume, partly offset by lower cigarette volume, as well as unfavorable cigarette mix; partly offset by higher marketing, administration and research costs (primarily due to inflationary impacts) as well as higher manufacturing costs.
Full-Year
Financial Summary - Years Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ Mix |
|
Cost/ Other |
|||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Net Revenues |
|
$ |
13,598 |
|
$ |
12,869 |
|
|
5.7 |
% |
3.7 |
% |
|
729 |
249 |
— |
540 |
(60 |
) |
— |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Operating Income |
|
$ |
6,012 |
|
$ |
5,802 |
|
|
3.6 |
% |
0.4 |
% |
|
210 |
186 |
— |
540 |
(79 |
) |
(437 |
) |
|||||||
Adjustments (1) |
|
|
(202 |
) |
|
(242 |
) |
|
16.5 |
% |
16.5 |
% |
|
40 |
— |
— |
— |
— |
|
40 |
|
|||||||
Adjusted Operating Income |
|
$ |
6,214 |
|
$ |
6,044 |
|
|
2.8 |
% |
(0.3 |
)% |
|
170 |
186 |
— |
540 |
(79 |
) |
(477 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Adjusted Operating Income Margin |
|
|
45.7 |
% |
|
47.0 |
% |
|
(1.3 |
)pp |
(1.8 |
)pp |
|
|
|
|
|
|
|
|||||||||
(1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated |
Net revenues increased by 3.7% on an organic basis, reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; partially offset by unfavorable volume/mix, mainly due to lower cigarette volume, as well as unfavorable cigarette mix, partly offset by higher HTU volume.
Adjusted operating income decreased by 0.3% on an organic basis, primarily reflecting: higher marketing, administration and research costs (mainly due to inflationary impacts and lower commercial investments in the prior year period); higher manufacturing costs (primarily due to inflationary impacts); and unfavorable volume/mix, mainly due to the same factors as for net revenues; partly offset by the favorable pricing variance.
SSEA, CIS & MEA REGION
Total Market, PMI Shipment & Market Share Commentaries
PMI Shipment Volume |
Fourth-Quarter |
|
Full-Year |
|||||||||
(million units) |
2023 |
2022 |
Change |
|
2023 |
2022 |
Change |
|||||
Cigarettes |
83,009 |
83,920 |
(1.1)% |
|
333,353 |
331,026 |
0.7% |
|||||
Heated Tobacco Units |
7,502 |
6,122 |
22.5% |
|
24,890 |
22,607 |
10.1% |
|||||
Total SSEA, CIS & MEA |
90,511 |
90,042 |
0.5% |
|
358,243 |
353,633 |
1.3% |
Fourth-Quarter
The estimated total market for cigarettes and HTUs in the Region decreased by approximately 1% to 389.2 billion units, due to a decline for cigarettes. The decrease in the estimated total market was mainly due to
PMI's total cigarette and HTU shipment volume in the Region increased by 0.5% to 90.5 billion units, mainly driven by
Full-Year
The estimated total market for cigarettes and HTUs in the Region decreased by approximately 2% to 1,528.6 billion units, due to a decline for cigarettes. The decrease in the estimated total market was predominantly due to
Our Regional market share increased by 0.8 points to 23.4%.
PMI's total cigarette and HTU shipment volume in the Region increased by 1.3% to 358.2 billion units, mainly driven by
Financial Summary
Fourth-Quarter
Financial Summary - Quarters Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ Mix |
|
Cost/ Other |
|||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Net Revenues |
|
$ |
2,707 |
|
$ |
2,686 |
|
|
0.8 |
% |
13.0 |
% |
|
21 |
|
(327 |
) |
— |
257 |
97 |
|
(6 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Income |
|
$ |
676 |
|
$ |
855 |
|
|
(20.9 |
)% |
3.0 |
% |
|
(179 |
) |
(205 |
) |
— |
257 |
(49 |
) |
(182 |
) |
|||||||
Adjustments (1) |
|
|
(5 |
) |
|
38 |
|
|
-(100 |
)% |
-(100 |
)% |
|
(43 |
) |
— |
|
— |
— |
— |
|
(43 |
) |
|||||||
Adjusted Operating Income |
|
$ |
681 |
|
$ |
817 |
|
|
(16.6 |
)% |
8.4 |
% |
|
(136 |
) |
(205 |
) |
— |
257 |
(49 |
) |
(139 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted Operating Income Margin |
|
|
25.2 |
% |
|
30.4 |
% |
|
(5.2 |
)pp |
(1.2 |
)pp |
|
|
|
|
|
|
|
|||||||||||
(1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated |
Net revenues increased by 13.0% on an organic basis, primarily reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing; and favorable volume/mix, driven by higher HTU volume and favorable cigarette mix, partly offset by lower cigarette volume.
Adjusted operating income increased by 8.4% on an organic basis, primarily reflecting: the favorable pricing variance, partly offset by higher marketing, administration and research costs; higher manufacturing costs (primarily due to inflationary impacts); and unfavorable volume/mix, mainly due to an unfavorable cigarette volume impact.
Full-Year
Financial Summary - Years Ended |
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ Mix |
|
Cost/ Other |
|||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Net Revenues |
|
$ |
10,629 |
|
$ |
10,467 |
|
|
1.5 |
% |
11.7 |
% |
|
162 |
|
(1,060 |
) |
— |
1,008 |
400 |
|
(186 |
) |
|||||||
Adjustment (1) |
|
|
(80 |
) |
|
— |
|
|
— |
% |
— |
% |
|
(80 |
) |
— |
|
— |
— |
— |
|
(80 |
) |
|||||||
Adjusted Net Revenues |
|
$ |
10,709 |
|
$ |
10,467 |
|
|
2.3 |
% |
12.4 |
% |
|
242 |
|
(1,060 |
) |
— |
1,008 |
400 |
|
(106 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Net Revenues |
|
$ |
10,629 |
|
$ |
10,467 |
|
|
1.5 |
% |
11.7 |
% |
|
162 |
|
(1,060 |
) |
— |
1,008 |
400 |
|
(186 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Income |
|
$ |
3,047 |
|
$ |
3,864 |
|
|
(21.1 |
)% |
(4.2 |
)% |
|
(817 |
) |
(653 |
) |
— |
1,008 |
(237 |
) |
(935 |
) |
|||||||
Adjustments (2) |
|
|
(178 |
) |
|
(56 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(122 |
) |
— |
|
— |
— |
— |
|
(122 |
) |
|||||||
Adjusted Operating Income |
|
$ |
3,225 |
|
$ |
3,920 |
|
|
(17.7 |
)% |
(1.1 |
)% |
|
(695 |
) |
(653 |
) |
— |
1,008 |
(237 |
) |
(813 |
) |
|||||||
Adjusted Operating Income Margin |
|
|
30.1 |
% |
|
37.5 |
% |
|
(7.4 |
)pp |
(4.5 |
)pp |
|
|
|
|
|
|
|
|||||||||||
(1) Termination of distribution arrangement in the |
||||||||||||||||||||||||||||||
(2) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated |
Adjusted net revenues increased by 12.4% on an organic basis, primarily reflecting: a favorable pricing variance, mainly driven by higher combustible tobacco pricing, with HTU pricing also higher; favorable volume/mix, primarily driven by favorable cigarette mix, as well as higher volume for HTUs, partly offset by an unfavorable cigarette volume impact; and partially offset by lower fees for certain distribution rights billed to customers in certain markets, shown in "Cost/Other."
Adjusted operating income decreased by 1.1% on an organic basis, primarily reflecting: higher marketing, administration and research costs; higher manufacturing costs (primarily due to inflationary impacts); unfavorable volume/mix, mainly due to an unfavorable cigarette volume impact and unfavorable cigarette mix, partly offset by higher HTU volume; and the impact of lower fees for certain distribution rights, as noted for net revenues; partially offset by the favorable pricing variance.
EA, AU AND PMI DF REGION
Total Market, PMI Shipment & Market Share Commentaries
PMI Shipment Volume |
Fourth-Quarter |
Full-Year |
||||||||||
(million units) |
2023 |
2022 |
Change |
2023 |
2022 |
Change |
||||||
Cigarettes |
11,287 |
12,335 |
(8.5)% |
50,689 |
54,251 |
(6.6)% |
||||||
Heated Tobacco Units |
11,958 |
12,785 |
(6.5)% |
50,519 |
40,613 |
24.4% |
||||||
Total EA, AU & PMI DF |
23,245 |
25,120 |
(7.5)% |
101,208 |
94,864 |
6.7% |
Fourth-Quarter
The estimated total market for cigarettes and HTUs in the Region, excluding
PMI's total cigarette and HTU shipment volume in the Region decreased by 7.5% to 23.2 billion units, driven by
PMI's estimated HTU adjusted in-market sales volume in the Region increased by 15.4% in the quarter, including growth in
Full-Year
The estimated total market for cigarettes and HTUs in the Region, excluding
Our Regional market share increased by 1.3 points to 30.0%.
PMI's total cigarette and HTU shipment volume in the Region increased by 6.7% to 101.2 billion units, mainly driven by
PMI's estimated HTU adjusted in-market sales volume in the Region increased by 15.8%, including growth in
Financial Summary
Fourth-Quarter
Financial Summary - Quarters Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ Mix |
|
Cost/ Other |
|||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Net Revenues |
|
$ |
1,430 |
|
$ |
1,478 |
|
|
(3.2 |
)% |
(0.1 |
)% |
|
(48 |
) |
(46 |
) |
— |
133 |
(135 |
) |
— |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Income |
|
$ |
561 |
|
$ |
678 |
|
|
(17.3 |
)% |
(5.2 |
)% |
|
(117 |
) |
(82 |
) |
— |
133 |
(133 |
) |
(35 |
) |
|||||||
Adjustments (1) |
|
|
— |
|
|
31 |
|
|
-(100 |
)% |
-(100 |
)% |
|
(31 |
) |
— |
|
— |
— |
— |
|
(31 |
) |
|||||||
Adjusted Operating Income |
|
$ |
561 |
|
$ |
647 |
|
|
(13.3 |
)% |
(0.6 |
)% |
|
(86 |
) |
(82 |
) |
— |
133 |
(133 |
) |
(4 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted Operating Income Margin |
|
|
39.2 |
% |
|
43.8 |
% |
|
(4.6 |
)pp |
(0.2 |
)pp |
|
|
|
|
|
|
|
|||||||||||
(1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated |
Net revenues decreased by 0.1% on an organic basis, reflecting: unfavorable volume/mix, mainly driven by lower cigarette and HTU volume; largely offset by favorable pricing variance, driven by higher combustible tobacco pricing.
Adjusted operating income decreased by 0.6% on an organic basis driven by the same factors as for net revenues.
Full-Year
Financial Summary - Years Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ Mix |
|
Cost/ Other |
||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net Revenues |
|
$ |
6,201 |
|
$ |
5,936 |
|
|
4.5 |
% |
11.2 |
% |
|
265 |
|
(400 |
) |
— |
206 |
459 |
— |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Operating Income |
|
$ |
2,481 |
|
$ |
2,424 |
|
|
2.4 |
% |
18.6 |
% |
|
57 |
|
(395 |
) |
— |
206 |
326 |
(80 |
) |
|||||||
Adjustments (1) |
|
|
(254 |
) |
|
(28 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(226 |
) |
— |
|
— |
— |
— |
(226 |
) |
|||||||
Adjusted Operating Income |
|
$ |
2,735 |
|
$ |
2,452 |
|
|
11.5 |
% |
27.7 |
% |
|
283 |
|
(395 |
) |
— |
206 |
326 |
146 |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Adjusted Operating Income Margin |
|
|
44.1 |
% |
|
41.3 |
% |
|
2.8 |
pp |
6.1 |
pp |
|
|
|
|
|
|
|
||||||||||
(1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated |
Net revenues increased by 11.2% on an organic basis, reflecting: favorable volume/mix, mainly driven by higher HTU volume, partly offset by lower cigarette volume and unfavorable smoke-free product mix (for HTUs and devices); and a favorable pricing variance, driven by higher combustible tobacco and device pricing, partly offset by lower HTU (net) pricing (primarily related to
Adjusted operating income increased by 27.7% on an organic basis, mainly reflecting favorable volume/mix, primarily driven by higher HTU volume, partly offset by lower cigarette volume and unfavorable HTU mix; the favorable pricing variance; and lower supply chain costs (primarily related to
Total Market, PMI Shipment & Market Share Commentaries
PMI Shipment Volume |
Fourth-Quarter |
Full-Year |
||||||||||
(million units) |
2023 |
2022 |
Change |
2023 |
2022 |
Change |
||||||
Cigarettes |
17,468 |
18,432 |
(5.2)% |
63,314 |
65,973 |
(4.0)% |
||||||
Heated Tobacco Units |
202 |
193 |
4.7% |
585 |
532 |
10.0% |
||||||
Total |
17,670 |
18,625 |
(5.1)% |
63,899 |
66,505 |
(3.9)% |
Fourth-Quarter
The estimated total market for cigarettes and HTUs in the Region, excluding the
PMI's total cigarette and HTU shipment volume in the Region decreased by 5.1% to 17.7 billion units, mainly due to
Full-Year
The estimated total market for cigarettes and HTUs in the Region, excluding the
Our Regional market share, excluding the
PMI's total cigarette and HTU shipment volume in the Region decreased by 3.9% to 63.9 billion units, mainly due to
Financial Summary
Fourth-Quarter
Financial Summary - Quarters Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ Mix |
|
Cost/ Other |
|||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Net Revenues |
|
$ |
545 |
|
$ |
536 |
|
|
1.7 |
% |
(4.9 |
)% |
|
9 |
|
35 |
|
— |
34 |
(62 |
) |
2 |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Income |
|
$ |
(79 |
) |
$ |
100 |
|
|
-(100 |
)% |
(56.0 |
)% |
|
(179 |
) |
(123 |
) |
— |
34 |
(55 |
) |
(35 |
) |
|||||||
Adjustments (1) |
|
|
(1 |
) |
|
5 |
|
|
-(100 |
)% |
-(100 |
)% |
|
(6 |
) |
— |
|
— |
— |
— |
|
(6 |
) |
|||||||
Adjusted Operating Income |
|
$ |
(78 |
) |
$ |
95 |
|
|
-(100 |
)% |
(52.6 |
)% |
|
(173 |
) |
(123 |
) |
— |
34 |
(55 |
) |
(29 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted Operating Income Margin |
|
|
(14.3 |
)% |
|
17.7 |
% |
|
(32.0 |
)pp |
(8.9 |
)pp |
|
|
|
|
|
|
|
|||||||||||
(1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated |
Net revenues decreased by 4.9% on an organic basis, primarily reflecting: unfavorable volume/mix, mainly due to lower cigarette volume and unfavorable cigarette mix; partly offset by a favorable pricing variance, driven by higher combustible tobacco pricing.
Adjusted operating income decreased by 52.6% on an organic basis, mainly reflecting: unfavorable volume/mix, mainly due to the same factors as for net revenues; higher marketing and administration costs (including incremental investments in the
Full-Year
Financial Summary - Years Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ Mix |
|
Cost/ Other |
|||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Net Revenues |
|
$ |
1,944 |
|
$ |
1,903 |
|
|
2.2 |
% |
(2.9 |
)% |
|
41 |
|
96 |
|
— |
128 |
(177 |
) |
(6 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Income |
|
$ |
62 |
|
$ |
436 |
|
|
(85.8 |
)% |
(40.6 |
)% |
|
(374 |
) |
(197 |
) |
— |
128 |
(139 |
) |
(166 |
) |
|||||||
Adjustments (1) |
|
|
(19 |
) |
|
(14 |
) |
|
(35.7 |
)% |
(35.7 |
)% |
|
(5 |
) |
— |
|
— |
— |
— |
|
(5 |
) |
|||||||
Adjusted Operating Income |
|
$ |
81 |
|
$ |
450 |
|
|
(82.0 |
)% |
(38.2 |
)% |
|
(369 |
) |
(197 |
) |
— |
128 |
(139 |
) |
(161 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted Operating Income Margin |
|
|
4.2 |
% |
|
23.6 |
% |
|
(19.4 |
)pp |
(8.6 |
)pp |
|
|
|
|
|
|
|
|||||||||||
(1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated |
Net revenues decreased by 2.9% on an organic basis, primarily reflecting: unfavorable volume/mix, mainly due to lower cigarette volume and unfavorable cigarette mix; partly offset by a favorable pricing variance, driven by higher combustible tobacco pricing.
Adjusted operating income decreased by 38.2% on an organic basis, mainly reflecting: higher marketing, administration and research costs (notably reflecting the same factors as in the quarter); unfavorable volume/mix, mainly due to the same factors as for net revenues; partly offset by the favorable pricing variance.
PMI Shipment Commentary
Swedish Match Oral Product Shipment Volume (1) |
Fourth-Quarter |
Full-Year |
||||||||||
(million cans) |
2023 |
2022 |
Change |
2023 |
2022 |
Change |
||||||
Nicotine Pouches |
|
|
|
|
|
|
||||||
|
116.3 |
34.5 |
+100% |
384.8 |
34.5 |
+100% |
||||||
Scandinavia |
7.1 |
3.7 |
90.9% |
28.7 |
3.7 |
+100% |
||||||
Other |
1.0 |
1.2 |
(15.1)% |
4.6 |
1.2 |
+100% |
||||||
Total Nicotine Pouches |
124.4 |
39.4 |
+100% |
418.2 |
39.4 |
+100% |
||||||
|
|
|
|
|
|
|
||||||
Snus |
|
|
|
|
|
|
||||||
Scandinavia |
55.5 |
39.3 |
41.4% |
218.2 |
39.3 |
+100% |
||||||
Other |
1.6 |
1.1 |
41.4% |
6.8 |
1.1 |
+100% |
||||||
Total Snus |
57.1 |
40.4 |
41.4% |
224.9 |
40.4 |
+100% |
||||||
|
|
|
|
|
|
|
||||||
Moist Snuff |
31.2 |
16.0 |
95.5% |
133.7 |
16.0 |
+100% |
||||||
|
|
|
|
|
|
|
||||||
Other |
0.8 |
— |
—% |
4.2 |
— |
—% |
||||||
|
|
|
|
|
|
|
||||||
Total Oral Products |
213.6 |
95.8 |
+100% |
781.0 |
95.8 |
+100% |
||||||
(1) Excluding |
|
|
|
|
|
|
Volume comparisons versus
Fourth-Quarter
Nicotine pouch shipment volume increased by 68.6% compared to
Shipment volume for snus declined by 17.6% compared to
Full-Year
Nicotine pouch shipment volume increased by 55.3% compared to
Shipment volume for snus declined by 13.8% compared to
Swedish Match Combustible Product Shipment Volume |
Fourth-Quarter |
Full-Year |
||||||||||
(million units) |
2023 |
2022 |
Change |
2023 |
2022 |
Change |
||||||
Cigars |
337.1 |
259.6 |
29.9% |
1,578.6 |
259.6 |
+100% |
Fourth-Quarter
Cigar shipment volume declined by 26.4% compared to
Full-Year
Cigar shipment volume declined by 12.2% compared to
Fourth-Quarter
Financial Summary - Quarters Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||
|
2023 |
|
2022 (2) |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ Mix |
|
Cost/ Other |
|||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Net Revenues |
|
$ |
682 |
|
$ |
316 |
|
|
+100 |
% |
21.2 |
% |
|
366 |
— |
|
299 |
|
25 |
42 |
— |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Operating Income / (Loss) |
|
$ |
227 |
|
$ |
(22 |
) |
|
+100 |
% |
+100 |
% |
|
249 |
(8 |
) |
97 |
|
25 |
38 |
97 |
|||||||
Adjustments (1) |
|
|
(98 |
) |
|
(151 |
) |
|
35.1 |
% |
62.3 |
% |
|
53 |
— |
|
(41 |
) |
— |
— |
94 |
|||||||
Adjusted Operating Income |
|
$ |
325 |
|
$ |
129 |
|
|
+100% |
51.2 |
% |
|
196 |
(8 |
) |
138 |
|
25 |
38 |
3 |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Adjusted Operating Income Margin |
|
|
47.7 |
% |
|
40.8 |
% |
|
6.9 |
pp |
10.1 |
pp |
|
|
|
|
|
|
|
|||||||||
(1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated |
||||||||||||||||||||||||||||
(2) |
PMI recorded net revenues of
PMI recorded adjusted operating income of
Full-Year
Financial Summary - Years Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||||
|
2023 |
|
2022 (2) |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ Mix |
|
Cost/ Other |
||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net Revenues |
|
$ |
2,496 |
|
$ |
316 |
|
|
+100 |
% |
21.2 |
% |
|
2,180 |
|
— |
|
2,113 |
|
25 |
42 |
— |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Operating Income |
|
$ |
824 |
|
$ |
(22 |
) |
|
+100 |
% |
+100 |
% |
|
846 |
|
(8 |
) |
694 |
|
25 |
38 |
97 |
|||||||
Adjustments (1) |
|
|
(390 |
) |
|
(151 |
) |
|
-(100 |
)% |
62.3 |
% |
|
(239 |
) |
— |
|
(333 |
) |
— |
— |
94 |
|||||||
Adjusted Operating Income |
|
$ |
1,214 |
|
$ |
129 |
|
|
+100 |
% |
51.2 |
% |
|
1,085 |
|
(8 |
) |
1,027 |
|
25 |
38 |
3 |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Adjusted Operating Income Margin |
|
|
48.6 |
% |
|
40.8 |
% |
|
7.8 |
pp |
10.1 |
pp |
|
|
|
|
|
|
|
||||||||||
(1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated |
|||||||||||||||||||||||||||||
(2) |
PMI recorded net revenues of
PMI recorded adjusted operating income of
WELLNESS AND HEALTHCARE
The operating results of PMI’s Vectura Fertin Pharma business are reported in the Wellness and Healthcare segment.
Financial Summary
Fourth-Quarter
Financial Summary - Quarters Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
||||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ Mix |
|
Cost/ Other |
|||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Net Revenues |
|
$ |
69 |
|
$ |
72 |
|
|
(4.2 |
)% |
(11.1 |
)% |
|
(3 |
) |
5 |
|
— |
(5 |
) |
— |
(3 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Operating Income / (Loss) |
|
$ |
(62 |
) |
$ |
(42 |
) |
|
(47.6 |
)% |
(35.7 |
)% |
|
(20 |
) |
(5 |
) |
— |
(5 |
) |
— |
(10 |
) |
|||||||
Adjustments (1) |
|
|
(15 |
) |
|
(13 |
) |
|
(15.4 |
)% |
(15.4 |
)% |
|
(2 |
) |
— |
|
— |
— |
|
— |
(2 |
) |
|||||||
Adjusted Operating Income / (Loss) |
|
$ |
(47 |
) |
$ |
(29 |
) |
|
(62.1 |
)% |
(44.8 |
)% |
|
(18 |
) |
(5 |
) |
— |
(5 |
) |
— |
(8 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Adjusted Operating Income / (Loss) Margin |
|
|
(68.1 |
)% |
|
(40.3 |
)% |
|
(27.8 |
)pp |
(25.3 |
)pp |
|
|
|
|
|
|
|
|||||||||||
(1) See Schedule 8 in Exhibit 99.2 to the Form 8-K dated |
Net revenues decreased by 11.1% on an organic basis. The adjusted operating loss of
Full-Year
Financial Summary - Years Ended |
|
|
|
|
|
Change Fav./(Unfav.) |
|
Variance Fav./(Unfav.) |
|||||||||||||||||||||
|
2023 |
|
2022 |
|
Total |
|
Excl. |
|
Total |
|
Cur- |
|
Acqui- |
|
Price |
|
Vol/ Mix |
|
Cost/ Other |
||||||||||
(in millions) |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Net Revenues |
|
$ |
306 |
|
$ |
271 |
|
|
12.9 |
% |
11.8 |
% |
|
35 |
|
3 |
|
— |
33 |
— |
(1 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Operating Income / (Loss) |
|
$ |
(870 |
) |
$ |
(258 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(612 |
) |
(6 |
) |
— |
33 |
— |
(639 |
) |
|||||||
Adjustments (1) |
|
|
(738 |
) |
|
(171 |
) |
|
-(100 |
)% |
-(100 |
)% |
|
(567 |
) |
— |
|
— |
— |
— |
(567 |
) |
|||||||
Adjusted Operating Income / (Loss) |
|
$ |
(132 |
) |
$ |
(87 |
) |
|
(51.7 |
)% |
(44.8 |
)% |
|
(45 |
) |
(6 |
) |
— |
33 |
— |
(72 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Adjusted Operating Income / (Loss) Margin |
|
|
(43.1 |
)% |
|
(32.1 |
)% |
|
(11.0 |
)pp |
(9.5 |
)pp |
|
|
|
|
|
|
|
||||||||||
(1) See Schedule 9 in Exhibit 99.2 to the Form 8-K dated |
Net revenues increased by 11.8% on an organic basis, notably reflecting the higher net revenues for smoking cessation products and select inhalation products.
The adjusted operating loss of
Forward-Looking and Cautionary Statements
This press release contains projections of future results and goals and other forward-looking statements, including statements regarding expected financial or operational performance; capital allocation plans; investment strategies; regulatory outcomes; market expectations; and business plans and strategies. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI.
PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of
PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year ended
Non-GAAP Measures, Glossary and Explanatory Notes
Reconciliations of non-GAAP measures in this release to the most directly comparable
Management reviews net revenues, gross profit, operating income, operating income margin, operating cash flow and earnings per share, or "EPS," on an adjusted basis, which may exclude the impact of currency and other items such as acquisitions, asset impairment and exit costs, tax items and other special items. Additionally, starting in 2022 and on a comparative basis, for these measures other than net revenues and operating cash flow, PMI includes adjustments to add back amortization expense on acquisition related intangible assets that are recorded as part of purchase accounting and contribute to PMI’s revenue generation, as well as impairment of intangible assets, if any. While amortization expense on acquisition related intangible assets is excluded in these adjusted measures, the net revenues generated from these acquired intangible assets are included in the company's adjusted measures, unless otherwise stated. Currency-neutral and organic growth rates reflect the way management views underlying performance for these measures. PMI believes that such measures provide useful insight into underlying business trends and results. Management reviews these measures because they exclude changes in currency exchange rates and other factors that may distort underlying business trends, thereby improving the comparability of PMI’s business performance between reporting periods. Furthermore, PMI uses several of these measures in its management compensation program to promote internal fairness and a disciplined assessment of performance against company targets. PMI discloses these measures to enable investors to view the business through the eyes of management.
Non-GAAP measures used in this release should neither be considered in isolation nor as a substitute for the financial measures prepared in accordance with
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appendix 1 |
|
|
|||||||||||||||||||||||||
Key Market Data |
|||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarters Ended |
|||||||||||||||||||||||||
Market |
|
Total Market, bio units |
|
PMI Shipments, bio units |
|
PMI Market Share, % (2) |
|||||||||||||||||||
|
|
Total |
|
Cigarette |
|
HTU |
|
Total |
|
HTU |
|||||||||||||||
|
2023 |
2022 |
% |
|
2023 |
2022 |
% |
|
2023 |
2022 |
% |
|
2023 |
2022 |
% |
|
2023 |
2022 |
pp |
|
2023 |
2022 |
pp |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total (1) (2) |
|
650.5 |
658.7 |
(1.2) |
|
185.1 |
186.0 |
(0.5) |
|
151.1 |
154.0 |
(1.9) |
|
34.0 |
32.0 |
6.1 |
|
28.6 |
28.1 |
0.5 |
|
4.9 |
4.3 |
0.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
7.1 |
7.7 |
(7.3) |
|
2.8 |
3.2 |
(13.7) |
|
2.7 |
3.1 |
(13.1) |
|
— |
0.1 |
(40.7) |
|
43.1 |
43.6 |
(0.5) |
|
0.7 |
0.8 |
(0.1) |
|
|
|
16.0 |
16.0 |
(0.2) |
|
6.6 |
7.1 |
(6.2) |
|
5.7 |
5.8 |
(2.2) |
|
1.0 |
1.3 |
(24.3) |
|
38.9 |
39.7 |
(0.8) |
|
5.6 |
4.7 |
0.9 |
|
|
|
18.2 |
17.8 |
2.5 |
|
10.6 |
10.2 |
4.0 |
|
6.5 |
6.4 |
2.0 |
|
4.1 |
3.8 |
7.5 |
|
54.7 |
54.3 |
0.4 |
|
19.0 |
15.4 |
3.6 |
|
|
|
13.1 |
12.8 |
2.3 |
|
5.6 |
5.1 |
10.6 |
|
4.3 |
4.1 |
6.5 |
|
1.3 |
1.0 |
27.8 |
|
42.8 |
39.6 |
3.2 |
|
9.6 |
7.7 |
1.9 |
|
|
|
10.6 |
10.6 |
(0.7) |
|
2.9 |
3.0 |
(2.5) |
|
2.6 |
2.8 |
(6.4) |
|
0.3 |
0.2 |
53.2 |
|
28.8 |
28.9 |
(0.1) |
|
2.4 |
1.9 |
0.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SSEA, CIS & MEA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
19.3 |
24.6 |
(21.8) |
|
6.2 |
5.9 |
5.2 |
|
5.6 |
5.4 |
3.8 |
|
0.6 |
0.5 |
21.7 |
|
31.4 |
22.2 |
9.2 |
|
2.0 |
0.9 |
1.1 |
|
|
|
72.5 |
73.4 |
(1.2) |
|
20.3 |
21.2 |
(4.1) |
|
20.3 |
21.2 |
(4.1) |
|
— |
— |
— |
|
28.0 |
28.9 |
(0.9) |
|
— |
— |
— |
|
|
|
10.7 |
13.0 |
(17.7) |
|
5.8 |
7.7 |
(25.5) |
|
5.7 |
7.6 |
(25.6) |
|
0.1 |
0.1 |
(15.0) |
|
53.7 |
59.4 |
(5.7) |
|
0.6 |
0.6 |
— |
|
|
|
52.4 |
52.1 |
0.6 |
|
16.5 |
16.1 |
2.4 |
|
11.4 |
12.0 |
(4.7) |
|
5.1 |
4.1 |
23.3 |
|
31.3 |
31.8 |
(0.5) |
|
8.3 |
7.8 |
0.5 |
|
|
|
35.3 |
31.1 |
13.3 |
|
18.7 |
15.7 |
19.0 |
|
18.7 |
15.7 |
19.0 |
|
— |
— |
— |
|
52.9 |
50.4 |
2.5 |
|
— |
— |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EA, AU & PMI DF |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
1.6 |
2.3 |
(32.4) |
|
0.5 |
0.8 |
(32.9) |
|
0.5 |
0.8 |
(32.9) |
|
— |
— |
— |
|
32.7 |
32.9 |
(0.2) |
|
— |
— |
— |
|
|
|
37.8 |
37.8 |
— |
|
13.9 |
16.1 |
(13.3) |
|
3.9 |
5.0 |
(21.2) |
|
10.0 |
11.1 |
(9.7) |
|
40.0 |
38.0 |
2.0 |
|
27.6 |
24.4 |
3.2 |
|
|
|
17.8 |
17.6 |
1.1 |
|
3.4 |
3.3 |
2.9 |
|
2.1 |
2.1 |
(2.3) |
|
1.3 |
1.2 |
12.2 |
|
19.3 |
19.1 |
0.2 |
|
7.5 |
6.7 |
0.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
7.1 |
7.8 |
(8.1) |
|
4.4 |
4.9 |
(10.7) |
|
4.4 |
4.9 |
(10.7) |
|
— |
— |
— |
|
61.7 |
63.5 |
(1.8) |
|
— |
— |
— |
|
|
|
8.8 |
9.6 |
(8.7) |
|
5.7 |
6.5 |
(11.6) |
|
5.7 |
6.4 |
(11.5) |
|
— |
— |
— |
|
65.3 |
67.4 |
(2.1) |
|
0.5 |
0.5 |
— |
|
(1) Market share estimates are calculated using IMS data, unless otherwise stated |
|||||||||||||||||||||||||
(2) Total market and market share estimates include cigarillos in |
|||||||||||||||||||||||||
(3) PMI market share reflects estimated adjusted in-market sales volume share. Historical HTU adjusted in-market sales volume share: Q1, 2023 (5.4%); Q2, 2023 (5.4%); Q3 2023 (4.9%). Historical total adjusted in-market sales volume share: Q1, 2023 (39.4%); Q2, 2023 (39.2%); Q3, 2023 (38.4%); |
|||||||||||||||||||||||||
Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appendix 2 |
|
|
|||||||||||||||||||||||||
Key Market Data |
|||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended |
|||||||||||||||||||||||||
Market |
|
Total Market, bio units |
|
PMI Shipments, bio units |
|
PMI Market Share, %(2) |
|||||||||||||||||||
|
|
Total |
|
Cigarette |
|
HTU |
|
Total |
|
HTU |
|||||||||||||||
|
2023 |
2022 |
% |
|
2023 |
2022 |
% |
|
2023 |
2022 |
% |
|
2023 |
2022 |
% |
|
2023 |
2022 |
pp |
|
2023 |
2022 |
pp |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total (1) (2) |
|
2,579.9 |
2,621.5 |
(1.6) |
|
738.2 |
731.1 |
1.0 |
|
612.9 |
621.9 |
(1.4) |
|
125.3 |
109.2 |
14.7 |
|
28.3 |
27.7 |
0.6 |
|
4.7 |
4.1 |
0.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
29.8 |
32.5 |
(8.2) |
|
13.0 |
14.0 |
(7.3) |
|
12.8 |
13.7 |
(7.2) |
|
0.2 |
0.2 |
(13.1) |
|
42.5 |
43.6 |
(1.1) |
|
0.7 |
0.7 |
— |
|
|
|
69.0 |
70.3 |
(1.8) |
|
26.5 |
28.2 |
(6.0) |
|
23.3 |
24.8 |
(5.7) |
|
3.1 |
3.4 |
(8.3) |
|
39.0 |
38.9 |
0.1 |
|
5.3 |
4.0 |
1.3 |
|
|
|
73.3 |
72.8 |
0.7 |
|
39.7 |
40.8 |
(2.8) |
|
27.3 |
28.6 |
(4.5) |
|
12.4 |
12.3 |
1.1 |
|
53.9 |
54.1 |
(0.2) |
|
17.3 |
14.6 |
2.7 |
|
|
|
56.7 |
55.7 |
1.8 |
|
23.7 |
21.7 |
9.4 |
|
18.7 |
17.1 |
9.0 |
|
5.0 |
4.5 |
10.8 |
|
41.8 |
38.9 |
2.9 |
|
8.9 |
8.2 |
0.7 |
|
|
|
43.6 |
44.6 |
(2.4) |
|
12.9 |
13.6 |
(5.5) |
|
11.8 |
12.7 |
(7.4) |
|
1.1 |
0.9 |
22.6 |
|
29.3 |
30.0 |
(0.7) |
|
2.3 |
1.7 |
0.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SSEA, CIS & MEA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
74.0 |
93.6 |
(20.9) |
|
24.3 |
21.0 |
15.4 |
|
23.0 |
20.0 |
14.8 |
|
1.3 |
1.0 |
26.9 |
|
32.8 |
22.2 |
10.6 |
|
1.7 |
0.8 |
0.9 |
|
|
|
291.6 |
304.0 |
(4.1) |
|
83.4 |
86.8 |
(4.0) |
|
83.4 |
86.8 |
(4.0) |
|
— |
— |
— |
|
28.6 |
28.6 |
— |
|
— |
— |
— |
|
|
|
42.9 |
53.4 |
(19.7) |
|
23.8 |
32.2 |
(26.2) |
|
23.5 |
32.0 |
(26.4) |
|
0.2 |
0.2 |
(0.9) |
|
55.4 |
60.3 |
(4.9) |
|
0.5 |
0.4 |
0.1 |
|
|
|
203.4 |
208.8 |
(2.6) |
|
64.8 |
64.7 |
0.1 |
|
47.9 |
49.3 |
(2.9) |
|
16.9 |
15.4 |
9.8 |
|
31.8 |
31.2 |
0.6 |
|
8.0 |
7.6 |
0.4 |
|
|
|
136.5 |
116.8 |
16.9 |
|
69.0 |
56.1 |
23.0 |
|
69.0 |
56.1 |
23.0 |
|
— |
— |
— |
|
50.5 |
48.0 |
2.5 |
|
— |
— |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EA, AU & PMI DF |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
7.2 |
8.9 |
(19.4) |
|
2.5 |
3.0 |
(16.0) |
|
2.5 |
3.0 |
(16.0) |
|
— |
— |
— |
|
34.8 |
33.4 |
1.4 |
|
— |
— |
— |
|
|
|
149.0 |
148.3 |
0.5 |
|
60.9 |
55.5 |
9.7 |
|
17.9 |
21.1 |
(15.4) |
|
43.0 |
34.4 |
25.1 |
|
39.6 |
37.6 |
2.0 |
|
26.7 |
23.6 |
3.1 |
|
|
|
72.0 |
72.6 |
(0.7) |
|
14.0 |
13.9 |
0.9 |
|
8.9 |
9.4 |
(5.0) |
|
5.1 |
4.5 |
13.1 |
|
19.5 |
19.2 |
0.3 |
|
7.1 |
6.2 |
0.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
28.8 |
30.3 |
(5.0) |
|
17.8 |
19.3 |
(7.9) |
|
17.8 |
19.3 |
(7.9) |
|
— |
— |
— |
|
61.9 |
63.8 |
(1.9) |
|
— |
— |
— |
|
|
|
30.0 |
32.2 |
(6.8) |
|
18.9 |
21.0 |
(9.8) |
|
18.8 |
20.8 |
(9.9) |
|
0.1 |
0.1 |
2.4 |
|
63.1 |
65.2 |
(2.1) |
|
0.5 |
0.4 |
0.1 |
|
(1) Market share estimates are calculated using IMS data, unless otherwise stated |
|||||||||||||||||||||||||
(2) Total market and market share estimates include cigarillos in |
|||||||||||||||||||||||||
(3) PMI market share reflects estimated adjusted in-market sales volume share |
|||||||||||||||||||||||||
Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20240207811391/en/
Investor Relations:
Lausanne: +41 (0)58 242 4666
InvestorRelations@pmi.com
Media:
Lausanne: +41 (0)58 242 4500
David.Fraser@pmi.com
Source:
Sign up for more information from PMI's Investor Relations team.
Get updates from our Investor Relations team
New PMI Investor Relations mobile app is now available
Our newly designed Investor Relations mobile application provides users with easier, more dynamic and comprehensive access to the company’s Investor Relations information, such as stock quotes, press releases, SEC filings, investor materials, and live and archived webcast playback of earnings calls and investor presentations.